Bio-techne Corp. Earnings

Bio-techne Corp.’s revenue fell -1% since last year same period to $286.56Mn in the Q3 2025. On a quarterly growth basis, Bio-techne Corp. has generated -9.59% fall in its revenue since last 3-months.

Bio-techne Corp.’s net profit jumped 13.63% since last year same period to $38.18Mn in the Q3 2025. On a quarterly growth basis, Bio-techne Corp. has generated 315.97% jump in its net profits since last 3-months.

Bio-techne Corp.’s net profit margin jumped 14.78% since last year same period to 13.32% in the Q3 2025. On a quarterly growth basis, Bio-techne Corp. has generated 338.89% jump in its net profit margins since last 3-months.

Bio-techne Corp.’s earning per share (EPS) estimates for the current quarter stand at 0.44 - a 1.28% jump from last quarter’s estimates.

Bio-techne Corp.’s earning per share (EPS) estimates for the current year stand at 0.44.

Bio-techne Corp.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q4 2025. This indicates that the Bio-techne Corp. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Bio-techne Corp. declared 0.08 dividend per share during the earnings announcement for Q4 2025.